Is Lincoln Pharmaceuticals Limited a good investment? Lincoln Pharmaceuticals Limited (LINCOLN.NS) is currently trading at 597.00 INR.
In terms of valuation, the stock trades at a P/E ratio of 13.60. This relatively low multiple may signal that Lincoln Pharmaceuticals Limited is undervalued compared to historical market norms.
For income investors, Lincoln Pharmaceuticals Limited pays a dividend yield of 0.30%. With a payout ratio of 4%, the dividend appears sustainable.
Yes, it pays an annual dividend of 1.80 INR (0.30% yield).
Lincoln Pharmaceuticals Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
1.80 INR
|
| Oct. 30, 2026 | 1.8000 |
| ▸2025 |
1.80 INR
|
| Oct. 30, 2025 | 1.8000 |
| ▸2024 |
1.80 INR
|
| Oct. 7, 2024 | 1.8000 |
| ▸2023 |
1.50 INR
|
| Oct. 30, 2023 | 1.5000 |
| ▸2022 |
1.50 INR
|
| Oct. 30, 2022 | 1.5000 |
| ▸2021 |
1.50 INR
|
| Oct. 30, 2021 | 1.5000 |
| ▸2020 |
1.50 INR
|
| March 28, 2020 | 1.5000 |
| ▸2019 |
1.50 INR
|
| Oct. 30, 2019 | 1.5000 |
| ▸2018 |
1.50 INR
|
| Oct. 29, 2018 | 1.5000 |
| ▸2017 |
1.20 INR
|
| Oct. 29, 2017 | 1.2000 |
| ▸2016 |
1.00 INR
|
| Oct. 30, 2016 | 1.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Lincoln Pharmaceuticals Limited | Oct 30, 2026 | Upcoming | 1.8 INR |
Community Discussion